ArticleHeliyon2025
Characteristics of microcrystalline cellulose derived from oil palm trunk slabs and its potential for use as tablet diluent.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Physicochemical characterization of banana pseudostem, peduncle, and leaf-derived microcrystalline cellulose as directly compressible excipients.Scientific reports · 2026Article
- Investigation of the drug release modifying property of Pentadesma butyracea gum in diclofenac sodium matrix tablets.PloS one · 2026Article
- Extraction Process Research and Characterization of Microcrystalline Cellulose Derived from Bamboo (Polymers · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work aimed to investigate the potential of cellulose extracted from oil palm trunk slabs (OPTS), residues from oil palm lumber processing for pharmaceutical tablets. Due to varying wood cell characteristics within the oil palm trunk which might affect the quality of the cellulose extracted from OPTS, the suitability of cellulose extracted from different positions within OPTS with respect to trunk height for tablet diluent was therefore explored in this work. OPTS from the trunk's bottom, middle, and top parts were collected. The vascular bundle and parenchyma tissue of each OPTS section were then mechanically separated and converted into powders. Cellulose was extracted from the powder and microcrystalline cellulose (MCC) was derived using acid hydrolysis. The powder and tablet compression properties of the MCC were then evaluated and compared with that of the commercial ones. MCC yields from both types of wood cells decreased from the bottom to the top of the trunk. MCC obtained from parenchyma tissue was more suitable for pharmaceutical tablets due to its finer texture and smaller particle size, and only parenchyma-derived MCC was used for further study; except MCC from the top part was ignored due to its relatively low MCC yield. Most of the parenchyma-derived MCC's properties obtained from the bottom part were greater than that of the middle part but slightly lower than that of the commercial MCC, Comprecel® M102. The study of tablet compression properties of the MCC revealed that the tablet prepared from the MCC of the bottom part met the general requirement for tablet manufacturing, indicating that it could be potentially used as tablet diluents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.